TO EVALUATE EFFECT OF BRAHMI VATI & SARASWATARISHTA IN ANXIETY (EXCESSIVE WORRY)
Phase 1
Not yet recruiting
- Conditions
- Health Condition 1: F01-F99- Mental, Behavioral and Neurodevelopmental disorders
- Registration Number
- CTRI/2020/09/027750
- Lead Sponsor
- DR VARSHA BALKRISHNA GONUGADE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1 Subjects fulfilling the diagnostic criteria of GAD (DSM V)
Exclusion Criteria
1 Laxana of Unmada (co-morbid psychiatric disorders)
2 Psychotropic drugs four weeks prior to study.
3 Patients with substance abuse like alcohol etc.
4 Patients with significant depression (BDI >17).
5 The patients with any other medical (Hypertension, Diabetes Mellitus)
6 Female patients who are pregnant and lactating.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method